BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioStrategy Partners - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioStrategy Partners
X-ORIGINAL-URL:https://biostrategypartners.org
X-WR-CALDESC:Events for BioStrategy Partners
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20211022T080000
DTEND;TZID=America/New_York:20211022T090000
DTSTAMP:20260403T195222
CREATED:20240729T234757Z
LAST-MODIFIED:20240729T234757Z
UID:1042-1634889600-1634893200@biostrategypartners.org
SUMMARY:OCTOBER 2021 PKS: THE RIGHT FIT – SELECTING A CRO
DESCRIPTION:Tips for Selecting and Working with a Contract Research Organization (CRO)\n \nCROs and related businesses known as CMOs and CDMOs are a critical part of the life sciences ecosystem\, offering everything from laboratory services for early-stage companies operating virtually to post-marketing surveillance for global pharmaceutical companies and everything in between. Not all are created alike\, however. Learn about the important differences among them\, how to select the right partner for your technology and tips for optimizing the relationship. \nMODERATOR: \nTina Catalone\, PhD\, PMP\, Senior Medical Innovation Program Manager\, Center for Medical Innovation\, Penn State College of Medicine\n \nPANELISTS: \nStephen Parent\, PhD\, Co-Founder\, VP Business Strategy & Development – Concurrent\, Kathera Biosciences Inc. \nNina Seme Nelson\, PhD\, Drug Discovery Leader\, Early Phase Development Solutions Team\, Labcorp Drug Development (Covance)\n \nREGISTER HERE!
URL:https://biostrategypartners.org/event/october-2021-pks-the-right-fit-selecting-a-cro/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210917T080000
DTEND;TZID=America/New_York:20210917T090000
DTSTAMP:20260403T195222
CREATED:20240729T235018Z
LAST-MODIFIED:20240729T235018Z
UID:1044-1631865600-1631869200@biostrategypartners.org
SUMMARY:SEPTEMBER 2021 PKS: MEDICAL DIAGNOSTICS AND INTELLECTUAL PROPERTY
DESCRIPTION:Making Sense of a Complex Landscape\n \nDevelopers of Medical Diagnostics face a complex and rapidly evolving intellectual property landscape. Successful commercialization of discoveries in this space requires an understanding of: \n\nThe pathway from biomarker to diagnostic tool\nHow IP aligns with clinical needs\nExpectations of commercialization partners\n\nThis month’s panel features a combination of legal\, industry\nand tech transfer experts who will share their knowledge of\nthis unique and important subsector of the life sciences. \nMODERATOR: \nPatrick J. Kelly\, Counsel\, Stradley Ronon \nPANELISTS: \nRianne Esquivel\, PhD\, Scientific Affairs Manager\, Fujirebio US\nJames Major\, DPhil\, Associate\, Stradley Ronon\nHeather Steinman\, PhD\, MBA\, Vice President for Business Development & Executive Director\, Technology Transfer\, The Wistar Institute \nREGISTER HERE!
URL:https://biostrategypartners.org/event/september-2021-pks-medical-diagnostics-and-intellectual-property/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210730T040000
DTEND;TZID=America/New_York:20210730T130000
DTSTAMP:20260403T195222
CREATED:20240729T235218Z
LAST-MODIFIED:20240729T235218Z
UID:1046-1627617600-1627650000@biostrategypartners.org
SUMMARY:JULY 2021 PKS: FINDING TALENT IN A COMPETITIVE MARKETPLACE
DESCRIPTION:How do you turn great science into a great business? By pooling the efforts and expertise of talented individuals. \nDuring this panel we’ll explore how to:\n \n\nIdentify and prioritize the skills and expertise needed to grow a life science business\nStrategies for finding and attracting the right hires \nCreative approaches to tapping professional expertise \nRegional workforce initiatives and training programs geared towards the life sciences industry\n\nPANELISTS: \n\nPatricia Day\, Manager\, Leadership Engagement\, The Chamber of Commerce for Greater Philadelphia\nEmma Thorp\,Chief Growth Officer\, RBW Consulting\, Boston and San Diego\n\nJames Pietropaolo\, Associate Director\, Office of Entrepreneurship and Commercialization\, Penn State University\n\nREGISTER HERE!
URL:https://biostrategypartners.org/event/july-2021-pks-finding-talent-in-a-competitive-marketplace/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210618T080000
DTEND;TZID=America/New_York:20210618T090000
DTSTAMP:20260403T195222
CREATED:20240729T235317Z
LAST-MODIFIED:20240729T235317Z
UID:1048-1624003200-1624006800@biostrategypartners.org
SUMMARY:JUNE 2021 PKS: WORKING WITH TECHNOLOGY TRANSFER OFFICES
DESCRIPTION:Best Practices for Faculty and Founders\n \nResearchers and would-be life sciences company founders\, this panel is designed especially for you! Learn directly from technology transfer professionals at some of Pennsylvania’s premier institutions how\, when and why to work with technology transfer offices to optimize the power of invention. \nTopics to be explored include:\n \n\nTips for effective communication with Technology Transfer Offices\nThe relationships among invention disclosures\, patents\, publications\, copyrights and trade secrets\nPatenting processes\, including timing and costs\nCommon myths about intellectual property\n\nPANELISTS: \n\nCamille Jolly-Tornetta\, PhD\, Director\, Office of Technology Transfer\, Children’s Hospital of Philadelphia\nTim Hurley\, Associate Director\, Office of Technology Management\, Penn State University\nNiraj J. Muni\, PhD\, MBA\, Associate Director\, Technology Commercialization\, Temple University\n\n\nREGISTER HERE!
URL:https://biostrategypartners.org/event/june-2021-pks-working-with-technology-transfer-offices/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210521T080000
DTEND;TZID=America/New_York:20210521T090000
DTSTAMP:20260403T195222
CREATED:20240729T235533Z
LAST-MODIFIED:20240729T235533Z
UID:1050-1621584000-1621587600@biostrategypartners.org
SUMMARY:MAY 2021 PKS: RAISING EARLY-STAGE CAPITAL – **VIEW THE RECORDING!**
DESCRIPTION:What You Need to Know about Angel Investment and Seed-Stage Venture Funding\n \nYou’ve invested both cash and sweat equity into your emerging life sciences company\, right? It’s likely you’ve received grant funding\, too\, as well as investment from “friends and family.” Nevertheless\, you’re going to need more money to reach the milestones that tend to attract a majority of venture capitalists (VCs) and strategic partners. \nWhere are you going to find that critical early-stage capital? We’ll discuss the people and organizations that typically invest in companies at this stage\, where to find them and tips for cultivating effective relationships. We’ll also explore the current investment climate and planning for future capital needs. \nMODERATOR: \n\nHeather Hunter\, Vice President\, Communications\, Venatorx Pharmaceuticals\n\nPANELISTS: \n\nFrederick (Rick) Jones\, Partner\, BioAdvance\nMark Mitchell\, Managing Director & Screening Committee Chair\, Delaware Crossing Investor Group\nJoseph P Hackett\, Director South Central Region\, Executive in Residence\, JD Brown Center for Entrepreneurship at York College of Pennsylvania\, Ben Franklin Technology Partners\n\nREGISTER HERE!
URL:https://biostrategypartners.org/event/may-2021-pks-raising-early-stage-capital-view-the-recording/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210517T080000
DTEND;TZID=America/New_York:20210517T093000
DTSTAMP:20260403T195222
CREATED:20240730T001752Z
LAST-MODIFIED:20240730T001752Z
UID:1083-1621238400-1621243800@biostrategypartners.org
SUMMARY:BIOSP-PKS - CUSTOMER DISCOVERY: BUILDING SOMETHING SOMEONE WANTS
DESCRIPTION:REGISTER HERE
URL:https://biostrategypartners.org/event/biosp-pks-customer-discovery-building-something-someone-wants/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210416T040000
DTEND;TZID=America/New_York:20210416T130000
DTSTAMP:20260403T195222
CREATED:20240729T235708Z
LAST-MODIFIED:20240729T235708Z
UID:1052-1618545600-1618578000@biostrategypartners.org
SUMMARY:APRIL 2021 PKS: "HIDDEN" RESOURCES – **VIEW THE RECORDING!**
DESCRIPTION:Are you aware that the Commonwealth of Pennsylvania\, as well as some county and local governments\, may have tax credit and funding programs available to you? Or that foundations often provide support for disease-specific or life sciences technology development? One of them just might be right for you! \n\n\nModerator:\n• Michael McCann\, President and Founder\, MVM Associates\n\nPanelists:\n• Kelly Wylam\, Director\, Innovation Partnership (IPart)\, Ben Franklin Technology Partners\n• Vered Nohi\, Executive Director\, Philadelphia-Israel Chamber of Commerce; Representative in PA\, DE and SNJ\, BIRD Foundation
URL:https://biostrategypartners.org/event/april-2021-pks-hidden-resources-view-the-recording/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201113T070000
DTEND;TZID=America/New_York:20201113T080000
DTSTAMP:20260403T195222
CREATED:20240729T235830Z
LAST-MODIFIED:20240729T235830Z
UID:1054-1605250800-1605254400@biostrategypartners.org
SUMMARY:WHAT'S YOUR EXIT STRATEGY? IT'S NEVER TOO EARLY TO START FORMULATING A PLAN
DESCRIPTION:It may seem odd to think about departing a business you’ve recently started\, but it’s never too early to begin thinking about if\, when\, and how you will exit. Do you expect the company will remain modest in size\, be listed on a stock exchange\, or something in between? Join the live webinar to listen to our panel of experts explore this topic and answer your questions.  Subjects to be explored may include: \n\n The legal structures and accounting practices that facilitate growth\n How to identify potential acquirers\nAcquisition readiness – the fundamentals and finding the right advisors\n\nJoin here
URL:https://biostrategypartners.org/event/whats-your-exit-strategy-its-never-too-early-to-start-formulating-a-plan/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201016T080000
DTEND;TZID=America/New_York:20201016T090000
DTSTAMP:20260403T195222
CREATED:20240729T235930Z
LAST-MODIFIED:20240729T235930Z
UID:1056-1602835200-1602838800@biostrategypartners.org
SUMMARY:STRATEGIC PARTNERSHIPS
DESCRIPTION:Strategic Partnerships: How to Select and Optimize Relationships with Other Businesses \nThe path to market for life sciences technologies can be long and challenging\, but working with the right strategic partner can significantly impact the timeline in a positive way. “Strategics\,” as they’re often called\, may also turn out be a crucial source of funding or become the eventual acquirer. \nLearn more about the valuable role they can play from our panel of experts. Topics such as: \n\n Distinguishing between vendor relationships and strategic partnerships\nIdentification of potential strategic partners\nEstablishing a shared set of goals and expectations
URL:https://biostrategypartners.org/event/strategic-partnerships/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200918T080000
DTEND;TZID=America/New_York:20200918T090000
DTSTAMP:20260403T195222
CREATED:20240730T000017Z
LAST-MODIFIED:20240730T000017Z
UID:1058-1600416000-1600419600@biostrategypartners.org
SUMMARY:DATA INTEGRITY AND REPRODUCABILITY
DESCRIPTION:While peer review and replication of results have long been a hallmark of high-quality research\, the scrutiny of results has intensified in recent years\, particularly in situations where the technology is bound for licensing or acquisition. Competition\, technological challenges\, economic pressure\, and rare but high-profile cases of fraud are all contributing to this phenomenon.
URL:https://biostrategypartners.org/event/data-integrity-and-reproducability/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200813T080000
DTEND;TZID=America/New_York:20200813T090000
DTSTAMP:20260403T195222
CREATED:20240730T000115Z
LAST-MODIFIED:20240730T000115Z
UID:1060-1597305600-1597309200@biostrategypartners.org
SUMMARY:DATA INTEGRITY AND REPRODUCIBILITY
DESCRIPTION:
URL:https://biostrategypartners.org/event/data-integrity-and-reproducibility/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200717T080000
DTEND;TZID=America/New_York:20200717T090000
DTSTAMP:20260403T195222
CREATED:20240730T000253Z
LAST-MODIFIED:20240730T000253Z
UID:1062-1594972800-1594976400@biostrategypartners.org
SUMMARY:PLAN TO SCALE FROM THE START
DESCRIPTION:
URL:https://biostrategypartners.org/event/plan-to-scale-from-the-start/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200619T080000
DTEND;TZID=America/New_York:20200619T090000
DTSTAMP:20260403T195222
CREATED:20240730T000346Z
LAST-MODIFIED:20240730T000346Z
UID:1064-1592553600-1592557200@biostrategypartners.org
SUMMARY:CONSIDERATIONS IN INTELLECTUAL PROPERTY: EXPERT INSIGHTS
DESCRIPTION:Join BioStrategy Partners\, our panel of experts\, and your peers from the academic and entrepreneurial communities for a discussion about IP considerations of particular interest to life sciences professionals.
URL:https://biostrategypartners.org/event/considerations-in-intellectual-property-expert-insights/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200410T080000
DTEND;TZID=America/New_York:20200410T090000
DTSTAMP:20260403T195223
CREATED:20240730T000444Z
LAST-MODIFIED:20240730T000444Z
UID:1066-1586505600-1586509200@biostrategypartners.org
SUMMARY:PRACTICAL KNOWLEDGE SERIES: CUSTOMER DISCOVERY
DESCRIPTION:Customer Discovery: Understanding Who Will Use\, Buy and Benefit from Your Invention \n You have an idea for a new product or service – great! Before spending precious limited resources developing the product take time to ensure there will be a sufficient market for what you build. Our panel of experts will talk about processes for identifying potential customers\, how to approach segmenting them\, and techniques for learning what they really want and need. \n Topics we’ll explore include: \n\n·       Interviews\, surveys\, observational studies and research reports – which tools to use and when\n·       What kinds of questions to ask when interviewing potential users and buyers\n·       Tips for prioritizing customer segments\n\nTo Register: https://www.eventbrite.com/e/april-pks-customer-discovery-tickets-97170253845
URL:https://biostrategypartners.org/event/practical-knowledge-series-customer-discovery/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200214T030000
DTEND;TZID=America/New_York:20200214T120000
DTSTAMP:20260403T195223
CREATED:20240730T000910Z
LAST-MODIFIED:20240730T000910Z
UID:1068-1581649200-1581681600@biostrategypartners.org
SUMMARY:INCUBATORS\, ACCELERATORS AND MORE...
DESCRIPTION:Topics to include:\n• Accelerators vs. incubators – what’s the difference?\n•   What    facilities    and    services    can    I    expect    to    find?\n• Leaving the nest – what to do when you’ve outgrown  the incubator \nSubmit questions through our registration process or  ask them during the broadcast!
URL:https://biostrategypartners.org/event/incubators-accelerators-and-more/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200117T070000
DTEND;TZID=America/New_York:20200117T080000
DTSTAMP:20260403T195223
CREATED:20240730T000947Z
LAST-MODIFIED:20240730T000947Z
UID:1070-1579244400-1579248000@biostrategypartners.org
SUMMARY:BUSINESS BASICS: WHAT EVERY LIFE SCIENCE ENTREPRENEUR NEEDS TO KNOW
DESCRIPTION:
URL:https://biostrategypartners.org/event/business-basics-what-every-life-science-entrepreneur-needs-to-know/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191115T070000
DTEND;TZID=America/New_York:20191115T083000
DTSTAMP:20260403T195223
CREATED:20240730T001041Z
LAST-MODIFIED:20240730T001041Z
UID:1072-1573801200-1573806600@biostrategypartners.org
SUMMARY:BIOSP - PKS - ACCELERATING GROWTH THROUGH STRATEGIC PARTNERSHIPS
DESCRIPTION:Learn what to consider when deciding  with whom to partner and when.\nYour expert panel includes Dr. John Younger of University City Science Center\nand Anthony Maher of University Place Associates \nStay tuned for more information! \nLocation: Webinar \nRemote Access will also be available!
URL:https://biostrategypartners.org/event/biosp-pks-accelerating-growth-through-strategic-partnerships/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191018T080000
DTEND;TZID=America/New_York:20191018T093000
DTSTAMP:20260403T195223
CREATED:20240730T001130Z
LAST-MODIFIED:20240730T001130Z
UID:1074-1571385600-1571391000@biostrategypartners.org
SUMMARY:BIOSP - PKS - CLINICAL TRIALS DESIGN
DESCRIPTION:Learn best practices and considerations relating to clinical trial design and how they can influence FDA approval from a group of experts. \nStay tuned for more information! \n\nRemote Access: \nhttps://www.eventbrite.com/e/the-imporance-of-clinical-trials-design-tickets-74268907301
URL:https://biostrategypartners.org/event/biosp-pks-clinical-trials-design/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190920T080000
DTEND;TZID=America/New_York:20190920T093000
DTSTAMP:20260403T195223
CREATED:20240730T001303Z
LAST-MODIFIED:20240730T001303Z
UID:1076-1568966400-1568971800@biostrategypartners.org
SUMMARY:BIOSP PKS: TERM SHEETS 101
DESCRIPTION:Not a finance expert? Not a problem! Join us for the FREE September edition of our Practical Knowledge Series. \nThe topic is finance basics for scientists and first-time entrepreneurs.  Our panel of experts will explain words and phrases commonly found in terms sheets\, help the audience understand the factors that influence a young company’s value\, and more. \nThank you to our sponsors:
URL:https://biostrategypartners.org/event/biosp-pks-term-sheets-101/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190719T080000
DTEND;TZID=America/New_York:20190719T093000
DTSTAMP:20260403T195223
CREATED:20240730T001405Z
LAST-MODIFIED:20240730T001459Z
UID:1078-1563523200-1563528600@biostrategypartners.org
SUMMARY:CREATIVE FUNDING SOURCES FOR LIFE SCIENCE ENTREPRENEURS
DESCRIPTION:
URL:https://biostrategypartners.org/event/creative-funding-sources-for-life-science-entrepreneurs/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190621T080000
DTEND;TZID=America/New_York:20190621T093000
DTSTAMP:20260403T195223
CREATED:20240730T001631Z
LAST-MODIFIED:20240730T001631Z
UID:1081-1561104000-1561109400@biostrategypartners.org
SUMMARY:BIOSP-PKS: COMPANY FORMATION
DESCRIPTION:Company Formation: avoiding mistakes\, reducing costs and structuring for growth! \nHearing from: \nJoseph Murphy – Caesar Rivise Intellectual Property Law \nJoseph Devine – Spector Gadon Rosen Vinci \nHarvey Hoffman – HZH Strategy\, LLC \nLearn about: \nSelecting an appropriate legal entity early in development \nHow to select and protect brand names\, logos\, domain names\, etc. before you start creating value \nDocumenting founders’ roles and responsibilities \nDeveloping & implementing IP strategies \nComplying with security laws and raising capital \nREGISTER HERE\n \nRemote Access: https://global.gotomeeting.com/join/752843797 | Access Code: 752-843-797 
URL:https://biostrategypartners.org/event/biosp-pks-company-formation/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190118T070000
DTEND;TZID=America/New_York:20190118T083000
DTSTAMP:20260403T195223
CREATED:20240730T001910Z
LAST-MODIFIED:20240730T001910Z
UID:1086-1547794800-1547800200@biostrategypartners.org
SUMMARY:REIMBURSEMENT AND HEALTH ECONOMICS
DESCRIPTION:Join us for our \nPRACTICAL KNOWLEDGE SERIES PANEL  \nFRIDAY\, JANUARY 18\, 2018 \n12:00 PM – 1:30 PM \nLUNCH PROVIDED \nReimbursement Strategies and \nHealth Economics \nThe aim of this panel is to deliver to scientists and entrepreneurs insights into reimbursement strategies and health economics considerations. \nGenerating robust clinical data and obtaining regulatory approval does not guarantee a sustainable revenue stream. Understanding how your technology is paid for is critical for assessing the viability of your product. And identifying reimbursement strategies sooner rather than later can help guide commercialization decisions. \nLocation: \nTemple University | MERB |  Room 710 \nRemote Access: https://global.gotomeeting.com/join/732264485  \nREGISTER HERE
URL:https://biostrategypartners.org/event/reimbursement-and-health-economics/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181116T070000
DTEND;TZID=America/New_York:20181116T083000
DTSTAMP:20260403T195223
CREATED:20240730T002704Z
LAST-MODIFIED:20240730T002704Z
UID:1088-1542351600-1542357000@biostrategypartners.org
SUMMARY:FUNDING SOURCES: ANGELS\, SBIR’S\, TAX CREDITS
DESCRIPTION:REGISTER HERE! \nCLICK FOR REMOTE ACCESS    \nDIRECTIONS AND PARKING
URL:https://biostrategypartners.org/event/funding-sources-angels-sbirs-tax-credits/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181008T033000
DTEND;TZID=America/New_York:20181008T130000
DTSTAMP:20260403T195223
CREATED:20240730T002822Z
LAST-MODIFIED:20240730T002822Z
UID:1090-1538969400-1539003600@biostrategypartners.org
SUMMARY:HEALTHCARE TECHNOLOGY EVENT
DESCRIPTION:SAVE THE DATE! \n\n\n\n\n\n\n\n\n\n\n\nThe Technology Council of Central PA\, in collaboration with the Center for Medical Innovation (CMI) at the Penn State College of Medicine and UPNext Fest 2018\, invite you to the Penn State Health campus in Hershey on Monday\, October 8th to explore some of the hottest topics and latest trends in the healthcare industry. This event will include cybersecurity\, 3D printing\, breakthroughs in telemedicine\, and artificial intelligence. Speakers will be announced soon!   \nREGISTER HERE!\n \n\n\n\n\n\n\n\n\nDoors open at 7:30 a.m. for networking and light refreshments. The main event will run from 8:00 a.m. until 12 noon in the Medical Center’s Junker Auditorium\, followed by an Innovation Café open networking lunch in the College’s central courtyard.
URL:https://biostrategypartners.org/event/healthcare-technology-event/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180921T080000
DTEND;TZID=America/New_York:20180921T093000
DTSTAMP:20260403T195223
CREATED:20240730T002922Z
LAST-MODIFIED:20240730T002922Z
UID:1092-1537516800-1537522200@biostrategypartners.org
SUMMARY:REGULATORY PATHWAYS AND CLINICAL TRIAL DESIGN
DESCRIPTION:JOIN US FOR THE 8TH 2018  \nPRACTICAL KNOWLEDGE SERIES PANEL  \nFriday\, September 21\, 2018 \n12:00 PM – 1:30 PM  \nLunch provided \nRegulatory Strategies and Clinical Trial Design  \nFor any technology to be successful\, the identification and pursuit of strategic opportunities for business growth and an exit must be done.  There are several aspects to consider when building a successful business and this panel is designed to induce investigators and entrepreneurs to comprehensively and strategically think about these concepts.  \nBench-top to bedside medical technologies require potential regulatory pathways to be evaluated and strategically pursued and clinical trials to be designed to survive intense scrutiny. The aim of this panel is to deliver insights into both regulatory strategies and clinical trial design to scientists and entrepreneurs.  \nPANELISTS \nChris Baumann \nGSK – Sr. Director of Global Regulatory Group \nTim Pelura \nBioMotiv – Executive in Residence \nNeal Thomas  \nPenn State Hershey – Associate Dean for Clinical Research \nLOCATION \nPennState Hershey Medical Center – Children’s Hospital \n600 University Drive Hershey\, PA 17033 \nRoom: P1106/P1106A \nRemote access: https://psu.zoom.us/s/984225584  \nDial-in:     US: +1 646 876 9923 or +1 669 900 6833 \nMeeting ID: 984 225 584
URL:https://biostrategypartners.org/event/regulatory-pathways-and-clinical-trial-design/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180720T080000
DTEND;TZID=America/New_York:20180720T093000
DTSTAMP:20260403T195223
CREATED:20240730T003015Z
LAST-MODIFIED:20240730T003015Z
UID:1094-1532073600-1532079000@biostrategypartners.org
SUMMARY:STRUCTURING AND PLANNING FOR GROWTH AND AN EXIT
DESCRIPTION:JOIN US FOR THE 7TH 2018  \nPRACTICAL KNOWLEDGE SERIES PANEL  \nFriday\, JULY 20\, 2018 \n12:00 PM – 1:30 PM \nStructuring for Growth and an Exit \nFor any technology to be successful\, the identification and pursuit of strategic opportunities for business growth and an exit must be done.  There are several aspects to consider when building a successful business and this panel is designed to induce investigators and entrepreneurs to comprehensively and strategically think about these concepts.  \nPANELISTS \nSeth Moskowitz \nEisnerAmper – Sr. Tax Manager \nDavid Gitlin \nRCCB Law – Partner \nChristina Pellicane \nUni. Delaware – Director of Commercialization Programs \nMODERATOR \nTodd Abrams \nTemple University – Senior Director of New Ventures and Business Development \nLOCATION \nEisnerAmper – Training room \n130 N 18th St #3000\, Philadelphia\, PA 19103 \nREMOTE ACCESS \nBy Computer: https://global.gotomeeting.com/join/822713669  \nBy Phone: +1 (646) 749-3112 
URL:https://biostrategypartners.org/event/structuring-and-planning-for-growth-and-an-exit/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180615T080000
DTEND;TZID=America/New_York:20180615T093000
DTSTAMP:20260403T195223
CREATED:20240730T003114Z
LAST-MODIFIED:20240730T003114Z
UID:1096-1529049600-1529055000@biostrategypartners.org
SUMMARY:STARTUP OR LICENSE?
DESCRIPTION:JOIN US FOR THE 6TH 2018\nPRACTICAL KNOWLEDGE SERIES PANEL \n12:00 PM – 1:30 PM\nSTARTUP OR LICENSE\nDuring the invention process you’ll encounter an early fork in the road: should you startup your own business\, or should you try to license your idea to an already established company or manufacturer? There are several factors to consider when making this decision\, and this panel aims to help you identify some of these factors and evaluate the pros and cons of each. \nPANELISTS\n\nHeather Rose\, PhD\, J.D.  \nThomas Jefferson University – Director\, Technology Licensing \nKathleen Rigaut\, PhD\, J.D. \nDann-Dorfman Herrell-Skillman Intellectual Property Law – Lawyer \nMichele Washko\, MBA \nBioStrategy Partners – Program Manager; Life Science Innovations – President \nMODERATOR\n\nKevin Harter\, MBA \nPenn State Harrisburg – Professor of Practice\, Science\, Engineering\, and Technology; Business Administration Director\, Center for Innovation and Entrepreneurship \nLOCATION\nThomas Jefferson University\nJefferson Alumni Hall – Room 407\n1020 Locust Street Philadelphia\, PA 19107\nRemote Access: http://library.jefferson.edu/videos/live/\n\n\nREGISTER HERE
URL:https://biostrategypartners.org/event/startup-or-license/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180518T080000
DTEND;TZID=America/New_York:20180518T093000
DTSTAMP:20260403T195223
CREATED:20240730T003210Z
LAST-MODIFIED:20240730T003210Z
UID:1098-1526630400-1526635800@biostrategypartners.org
SUMMARY:BUILDING RELATIONSHIPS WITH STRATEGIC PARTNERS
DESCRIPTION:Friday\, May 18\, 2018 \n12-1:30 PM \nLunch Provided \nTemple University – MERB 1010 \nRemote Access: https://global.gotomeeting.com/join/339599381\n \nDial-in: +1 (786) 535-3211 (Access code: 339-599-381) \n \nFor medical innovations to be successful\, it takes a skilled team and strong collaborations\, but knowing when and who to partner with can be daunting\, especially with the constantly changing commercialization ecosystem.  \nThis panel aims to aid in your navigation of current potential partners\, identify what industry partners are looking for and to describe novel programs that connect various life sciences entities for the ultimate goal of technology commercialization.  \n \nTed Torphy\, Ph.D.  BioMotiv\, Chief Scientific Officer \nMichael Blaustein\, Ph.D. NCET2\, Startup Development Officer \nSimon Kassas\, AmpTech & Advanced Plasma Solutions – Vice President \n \nMichele Washko\, MA\, MBA\, BioStrategy Partners – Program Director
URL:https://biostrategypartners.org/event/building-relationships-with-strategic-partners/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180516T080000
DTEND;TZID=America/New_York:20180516T093000
DTSTAMP:20260403T195223
CREATED:20240730T003543Z
LAST-MODIFIED:20240730T003543Z
UID:1103-1526457600-1526463000@biostrategypartners.org
SUMMARY:FRONTIERS IN HEALTHCARE DISCOVERY AND INTELLECTUAL PROPERTY PROTECTION: WHAT ARE THE RAMIFICATIONS FOR IN SILICO MODELING\, ALGORITHMS\, AND IT ENABLED THERAPIES
DESCRIPTION:https://universityofthesciences.adobeconnect.com/rnlkz7cbzxfo/ \n \n \n \n\n \nFriday\, March 16\, 2018 \n12-1:30pm \nUniversity of the Sciences – IPEX 139 \nOR  \nJoin us Remotely through Adobe Connect: \nMeeting Name: BioStrategy Partners \nTo join the meeting:  \nhttps://universityofthesciences.adobeconnect.com/rnlkz7cbzxfo/ \nMany of today’s emerging health technologies no longer fit neatly into a single category like “novel therapeutic” or “medical device.” Increasingly\, new healthcare products combine computers\, algorithms\, and novel materials with drugs and devices in new and powerful ways. As a consequence\, the intellectual property (IP) landscape surrounding healthcare advances is becoming increasingly diverse and complex. \nThis panel will explore newer modes of discovery and development and help inventors and entrepreneurs alike further their  understanding of where new opportunities may reside and what constitutes protectable IP in this rapidly evolving environment. \n \nLance M. Westerhoff\, Ph.D.  QuantumBio – President and General Manager \nHis experience includes project management and  leadership; software engineering and development; strategic planning; and fund raising efforts including angel\, venture capital\, and public/grant funding. He is also a published scientist with projects involving the synergistic application of quantum mechanics and molecular mechanics in the life and pharmaceutical sciences. He has successfully overseen the research\, development\, and deployment of advanced technology within the Company\, and through his extensive contacts\, he has been able to market these tools to the pharmaceutical industry.\n \nKenneth N. Nigon Schwegman Lundberg Woessner – Attorney \nKenneth Nigon has been an IP lawyer for 32 years.  Ken’s practice focuses on US and international patent protection for computer hardware\, software\, and business methods. Ken is a co-chair and a member of the Practising Law Institute faculty for the annual Advanced Patent Prosecution Workshop. Ken is a contributing author for Electronic and Software Patents: Law and Practice\, a treatise published by BNA Books. Ken is a past-president of the Philadelphia Intellectual Property Law Association and has served on the board of directors and held many committee leadership positions in the American Intellectual Property Law Association where he currently serves as vice-chair of the Patent Relations with the USPTO Committee.  He earned recognition and is listed in Chambers & Partners America’s Leading Lawyers for Business\, in The Best Lawyers in America and in Pennsylvania Super Lawyers. \nJoel Shertok\, Ph.D. Advanced Plasma Solutions – Director of Technical Services \nDr. Joel Shertok received his B.E. in Chemical Engineering from The Cooper Union in New York City and his Ph.D. in Chemical Engineering from Princeton University. Dr. Shertok has spent an extensive career in industrial process research and process development\, working for such companies as Union Carbide (Bound Brook\, NJ) and Amoco Corporation (Atlanta\, GA and Naperville\, IL) all in a variety of senior managerial and technical positions. Dr. Shertok’s particular area of expertise is in process development\, scale-up\, and commercialization of new processes and products\, from the bench to pilot plant to full manufacture. Dr. Shertok is also committed to the AmpTech accelerator group which catalyzes the development and strategic planning of diverse and cutting-edge  prototypes.  \n\n\n \n \nPatrick Kelly\, Riverside Law – Partner \nPat’s experience in the Life Sciences industry began as an academic scientist culminating in the successful completion of his Ph.D. in molecular biology at the Georgia Institute of Technology. Pat began his career in patent law in 1991 when he joined an intellectual property boutique working as a patent agent by day while attending law school in the evening. Following law school graduation\, Pat developed a robust practice advising pharmaceutical\, biotechnology\, and scientific instrumentation companies and venture capitalists in all facets of patent law.
URL:https://biostrategypartners.org/event/frontiers-in-healthcare-discovery-and-intellectual-property-protection-what-are-the-ramifications-for-in-silico-modeling-algorithms-and-it-enabled-therapies/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180420T080000
DTEND;TZID=America/New_York:20180420T093000
DTSTAMP:20260403T195223
CREATED:20240730T003313Z
LAST-MODIFIED:20240730T003313Z
UID:1101-1524211200-1524216600@biostrategypartners.org
SUMMARY:SURVIVING DATA SCRUTINY
DESCRIPTION:Join us for the 4th 2018 Practical Knowledge Series Panel.
URL:https://biostrategypartners.org/event/surviving-data-scrutiny/
END:VEVENT
END:VCALENDAR